None listed
Conditions
Interventions
Drug : In the case of the morning test, the Plenvu acid group prepared a solution according to the method of preparing the drug the evening before the test, and then took 500 mL of the prepared soluti
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients hospitalized for colonoscopy treatment such as polypectomy 2. Patients who are asymptomatic and visited the gastroenterology department for screening or surveillance colonoscopy for colon cancer screening purposes
Exclusion criteria
Exclusion criteria: 1. Men or women under the age of 18 2. Patients with chronic bowel disease, including inflammatory bowel disease 3. Patients with massive bloody stool 4. Patients with renal dysfunction (CKD stage IV or higher) 5. Patients for the purpose of follow-up after colon cancer surgery and pret-reatment before colon surgery 6. People with mental retardation or cognitive impairment who are unable to make voluntary decisions 7. When other researchers judge that participation in research is inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston bowel preparation scale;Cecal intubaiton;Insertion time | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with taking;Compliance;Satisfaction with flavor;Willingness to switch to another bowel preparation drug;Willingness to reuse the same bowel preparation drug;Dosage;Adverse event | — |
Countries
Korea, Republic of
Contacts
Public ContactJin Hwa Park
Asan Medical Center
Outcome results
None listed